Genes involved in MAMs formation whose expression was altered only in glioma samples were FUNDC1, FACL4, VDAC1, ATP6AP2, CISD2, ERO1A, TP53I11, MAVS, and CDK5RAP3, while those altered only in GB and not in gliomas were TDRKH, SOAT1, LMAN1, TRIM4, CAV1, BAX, ITGB1, SEC61B, PDIA6, CFLAR, RAB32, MTTP, TMPO, ELOVL1, PKMYT1, p66shc/SHC1, PEMT, LRRC59, BET1, TBL2, ALG9, TOMM5, SERAC1, TCHP, VMA21, RPS7, PTRH2, ATG5, CHCHD2, SCD5, SERP1, PCCA, and CKAP4 (Supplementary Table S3). This evidence concerns the gene TP53I11 and central nervous system cancer.